Allergen Immunotherapy and Possible Clinical Remission: Toward a Disease-Modifying Paradigm in Allergic Disorders
Fabiana Furci, Remo Poto, Corrado Pelaia, Gilda Varricchi, Chiara Lupia, Vincenzo Patella, Gianenrico Senna, Girolamo Pelaia, Giorgio Walter Canonica · 2026
Read Allergen Immunotherapy and Possible Clinical Remission: Toward a Disease-Modifying Paradigm in Allergic Disorders by Fabiana Furci, Remo Poto, Corrado Pelaia, Gilda Varricchi, Chiara Lupia, Vincenzo Patella, Gianenrico Senna, Girolamo Pelaia, Giorgio Walter Canonica (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13297453.txt.
Description
Should allergy shots aim higher than symptom relief? Fabiana Furci and co-authors argue in a 2026 review that allergen immunotherapy should be judged by whether it can deliver lasting clinical remission. They trace how the field's goals have shifted from control toward changing the disease itself.
Immunotherapy remains the only treatment that modifies IgE-mediated allergic disease rather than masking it. The authors review definitions of remission in allergic rhinitis and asthma, where remission includes freedom from symptoms, no systemic steroid use, and stable lung function. They weigh the evidence that treatment can hold benefits after it stops and discuss tools clinics could use to recognize remission in everyday practice.
Catalog record
| CREATOR | Fabiana Furci, Remo Poto, Corrado Pelaia, Gilda Varricchi, Chiara Lupia, Vincenzo Patella, Gianenrico Senna, Girolamo Pelaia, Giorgio Walter Canonica |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49391 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |